A clinical formulation indicated for Diabetes. Facilitates improved insulin sensitivity in muscle and adipose tissue to support better glycemic control.
An oral antidiabetic agent utilized to manage blood sugar levels in type 2 diabetes by helping to target insulin sensitivity to support glycemic control.
Mechanism of Action
It activates specific receptors (PPAR-gamma) in fat, muscle, and liver cells. This activation increases the cells' sensitivity to insulin, allowing the body to use its own insulin more effectively and reducing glucose production in the liver.
Route of Administration
Oral
Onset Time
Several weeks
Duration
24 hours
Contraindications
Heart failure, Bladder cancer, Diabetic ketoacidosis, Allergy to pioglitazone
Information for Actos is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
